Pacer Advisors, Inc. Alector, Inc. Transaction History
Pacer Advisors, Inc.
- $39 Billion
- Q2 2024
A detailed history of Pacer Advisors, Inc. transactions in Alector, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 572 shares of ALEC stock, worth $2,585. This represents 0.0% of its overall portfolio holdings.
Number of Shares
572
Previous 1,288
55.59%
Holding current value
$2,585
Previous $7,000
71.43%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ALEC
# of Institutions
165Shares Held
58.1MCall Options Held
57KPut Options Held
14.9K-
Black Rock Inc. New York, NY9.1MShares$41.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$24.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.63MShares$20.9 Million0.69% of portfolio
-
Morgan Stanley New York, NY3.01MShares$13.6 Million0.0% of portfolio
-
State Street Corp Boston, MA2.79MShares$12.6 Million0.0% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $373M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...